Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0494 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0494 |
Peptide Name | Exendin-3 |
PEPTIDE SEQUENCE (1-letter) | HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
PEPTIDE SEQUENCE (3-letter) | His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser |
N-terminal modification | NA |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 31 |
Conformation | Linear |
Peptide Nature | NA |
Source/Origin of peptide | rat |
SMILES | [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O |
Cell Line | NA |
In vitro CONCENTRATION | NA |
In vitro METHOD | NA |
In vitro RESULT | NA |
ANIMAL MODEL | NA |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | Intravenous |
In vivo METHOD | NA |
In vivo RESULT | NA |
ACTION | NA |
TRANSPORT TYPE | Permeability |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | NA |
PHYSICAL CONDITION | NA |
RESPONSE | % injected dose |
RESULT | 0.046 %/g |
LABEL | Direct iodination |
PMID | 9663454 |